中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/17 | 6,790 | 6,898 | 6,778 | 6,867 | +147 | +2.2% | 2,637,300 |
| 2024/09/13 | 6,732 | 6,820 | 6,686 | 6,720 | -112 | -1.6% | 3,749,000 |
| 2024/09/12 | 6,680 | 6,883 | 6,630 | 6,832 | +352 | +5.4% | 2,679,100 |
| 2024/09/11 | 6,585 | 6,639 | 6,441 | 6,480 | -104 | -1.6% | 1,924,800 |
| 2024/09/10 | 6,533 | 6,710 | 6,484 | 6,584 | +37 | +0.6% | 2,099,100 |
| 2024/09/09 | 6,477 | 6,573 | 6,396 | 6,547 | -30 | -0.5% | 1,773,800 |
| 2024/09/06 | 6,625 | 6,763 | 6,577 | 6,577 | -48 | -0.7% | 2,131,300 |
| 2024/09/05 | 6,850 | 6,882 | 6,612 | 6,625 | -318 | -4.6% | 2,050,900 |
| 2024/09/04 | 6,889 | 7,012 | 6,810 | 6,943 | -174 | -2.4% | 2,384,100 |
| 2024/09/03 | 6,995 | 7,117 | 6,957 | 7,117 | +181 | +2.6% | 1,866,900 |
| 2024/09/02 | 7,281 | 7,346 | 6,865 | 6,936 | -448 | -6.1% | 2,663,900 |
| 2024/08/30 | 7,400 | 7,485 | 7,270 | 7,384 | +1 | ±0% | 2,387,600 |
| 2024/08/29 | 7,335 | 7,428 | 7,285 | 7,383 | +48 | +0.7% | 1,495,600 |
| 2024/08/28 | 7,358 | 7,410 | 7,220 | 7,335 | -1 | ±0% | 1,584,400 |
| 2024/08/27 | 7,150 | 7,359 | 7,135 | 7,336 | +237 | +3.3% | 2,053,500 |
| 2024/08/26 | 7,070 | 7,143 | 6,859 | 7,099 | -121 | -1.7% | 2,184,600 |
| 2024/08/23 | 7,200 | 7,377 | 7,135 | 7,220 | +106 | +1.5% | 3,058,800 |
| 2024/08/22 | 7,000 | 7,248 | 6,980 | 7,114 | +266 | +3.9% | 3,451,500 |
| 2024/08/21 | 6,876 | 7,000 | 6,843 | 6,848 | -85 | -1.2% | 1,725,900 |
| 2024/08/20 | 6,759 | 6,985 | 6,680 | 6,933 | +147 | +2.2% | 2,406,100 |
| 2024/08/19 | 6,819 | 6,886 | 6,696 | 6,786 | -74 | -1.1% | 2,051,900 |
| 2024/08/16 | 6,684 | 6,888 | 6,663 | 6,860 | +272 | +4.1% | 2,930,900 |
| 2024/08/15 | 6,460 | 6,628 | 6,441 | 6,588 | +210 | +3.3% | 2,775,000 |
| 2024/08/14 | 6,321 | 6,399 | 6,260 | 6,378 | +139 | +2.2% | 2,137,700 |
| 2024/08/13 | 6,118 | 6,284 | 6,114 | 6,239 | +117 | +1.9% | 2,384,700 |
| 2024/08/09 | 6,129 | 6,294 | 6,057 | 6,122 | +155 | +2.6% | 3,771,400 |
| 2024/08/08 | 5,900 | 6,118 | 5,823 | 5,967 | -205 | -3.3% | 2,832,200 |
| 2024/08/07 | 5,866 | 6,443 | 5,853 | 6,172 | +125 | +2.1% | 4,158,100 |
| 2024/08/06 | 6,140 | 6,287 | 5,866 | 6,047 | +107 | +1.8% | 4,596,900 |
| 2024/08/05 | 6,235 | 6,366 | 5,853 | 5,940 | -460 | -7.2% | 4,613,300 |
| 2024/08/02 | 6,370 | 6,548 | 6,345 | 6,400 | -80 | -1.2% | 3,146,300 |
| 2024/08/01 | 6,409 | 6,557 | 6,364 | 6,480 | -129 | -2% | 2,224,400 |
| 2024/07/31 | 6,549 | 6,611 | 6,408 | 6,609 | +59 | +0.9% | 2,841,200 |
| 2024/07/30 | 6,439 | 6,563 | 6,357 | 6,550 | +211 | +3.3% | 2,587,600 |
| 2024/07/29 | 6,210 | 6,437 | 6,205 | 6,339 | +75 | +1.2% | 2,089,300 |
| 2024/07/26 | 6,326 | 6,402 | 6,191 | 6,264 | +238 | +3.9% | 3,551,800 |
| 2024/07/25 | 6,100 | 6,198 | 5,980 | 6,026 | -136 | -2.2% | 2,855,200 |
| 2024/07/24 | 5,986 | 6,214 | 5,970 | 6,162 | +151 | +2.5% | 2,122,800 |
| 2024/07/23 | 5,915 | 6,048 | 5,915 | 6,011 | +82 | +1.4% | 1,079,400 |
| 2024/07/22 | 5,929 | 6,000 | 5,893 | 5,929 | +29 | +0.5% | 1,943,200 |
| 2024/07/19 | 5,897 | 5,942 | 5,806 | 5,900 | -83 | -1.4% | 2,575,600 |
| 2024/07/18 | 5,959 | 6,035 | 5,856 | 5,983 | -76 | -1.3% | 2,986,900 |
| 2024/07/17 | 6,120 | 6,128 | 6,033 | 6,059 | -5 | -0.1% | 2,731,600 |
| 2024/07/16 | 6,219 | 6,230 | 6,058 | 6,064 | -220 | -3.5% | 2,668,900 |
| 2024/07/12 | 6,254 | 6,371 | 6,226 | 6,284 | -70 | -1.1% | 4,467,200 |
| 2024/07/11 | 6,412 | 6,429 | 6,321 | 6,354 | -41 | -0.6% | 2,624,200 |
| 2024/07/10 | 6,286 | 6,425 | 6,257 | 6,395 | +108 | +1.7% | 2,698,600 |
| 2024/07/09 | 6,153 | 6,323 | 6,098 | 6,287 | +94 | +1.5% | 2,462,100 |
| 2024/07/08 | 6,181 | 6,359 | 6,162 | 6,193 | -7 | -0.1% | 3,155,700 |
| 2024/07/05 | 6,127 | 6,211 | 6,122 | 6,200 | +100 | +1.6% | 2,170,700 |
151～
200
件表示中 / 3691件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 843,900円 | +1.7% | +5.0% | 2.96% | 33.87倍 | 7.30倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 365,500円 | +6.0% | +4.0% | 2.13% | 22.69倍 | 4.19倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 437,200円 | +7.7% | +206.9% | 4.48% | 58.47倍 | 0.99倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 731,500円 | +2.2% | +10.2% | 1.64% | 14.05倍 | 1.41倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 143,900円 | +0.9% | +380.2% | 5.42% | 19.82倍 | 1.70倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
